Miranda G. Loutet

Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000–2015

M. Lalor, M. Loutet, J. Davidson, 2018, Emerging infectious diseases.

National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area

M. Loutet, H. Kunst, N. Jayasekera, 2018, European Respiratory Journal.

Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation

Ross J. Harris, Ross J Harris, M. Loutet, 2017, European Respiratory Journal.

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance

Ross J. Harris, B. Haselden, W. Lynn, 2019, European Respiratory Journal.

Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study.

P. White, A. Hayward, I. Abubakar, 2016, The Lancet. Infectious diseases.

Delay from symptom onset to treatment start among tuberculosis patients in England, 2012–2015

M. Lalor, H. L. Thomas, C. Cosgrove, 2018, Epidemiology and Infection.

English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2010 to 2014: report 2015

C. Mcnulty, R. Guy, N. Woodford, 2015 .

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002–2014

M. Lalor, I. Abubakar, M. Loutet, 2017, Emerging infectious diseases.